“…In case of COVID-19 vaccination, vaccine-induced immune thrombotic thrombocytopenia (VITT), which can lead to cerebral venous sinus thrombosis, has been found to be particularly associated with the adenovirus vector-based COVID-19 vaccines [234] , [235] , [236] , [237] , [238] , [239] , [240] , [241] , [242] . Another example are retinal artery/vein occlusions induced by SARS-CoV-2 infection [243] , [244] , [245] , [246] , [247] , [248] , [249] , [250] , [251] , [252] , [253] , [254] , [255] , [256] , [257] , [258] , [259] , [260] , [261] , [262] and COVID-19 vaccination [263] , [264] , [265] , [266] , [267] , [268] , [269] , [270] , [271] , [272] , [273] , [274] , [275] , [276] , [277] , [278] , [279] , [280] , [281] , [282] , [283] , [284] , [285] , [286] , [287] , [288] , [289] , [290] , [291] , [292] , which can thus can be considered part of the symptoms of COVID-19 and PCVS. Noteworthy, induced retinal artery/vein occlusions induced COVID-19 vaccination were found to be “more common than anticipated” [263] .…”